Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine Minimisation vs Withdrawal in Renal Transplant
NCT00541814Phase 4Unknown
- Sponsor
- University Hospitals Birmingham
- Start
- Oct 2007
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cyclosporine in Chronic Allograft Kidney Disease (CKaD), sponsored by University Hospitals Birmingham. Primary endpoint: Renal allograft markers of damage and evolving injury at 16 months. Status: unknown.
02
Drugs
cyclosporine
03
Conditions
Chronic Allograft Kidney Disease (CKaD)
Beyond the preview
Go deeper on NCT00541814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541814.